The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 12, 2021

Filed:

Mar. 09, 2016
Applicants:

National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, JP;

Osaka University, Osaka, JP;

Inventors:

Hiroyuki Mizuguchi, Osaka, JP;

Kazuo Takayama, Osaka, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); C12N 1/00 (2006.01); C12N 5/10 (2006.01); G01N 33/50 (2006.01); C12N 5/071 (2010.01); C12Q 1/02 (2006.01);
U.S. Cl.
CPC ...
C12N 5/10 (2013.01); C12N 5/067 (2013.01); C12N 5/0679 (2013.01); C12Q 1/025 (2013.01); G01N 33/5073 (2013.01); C12N 2501/11 (2013.01); C12N 2501/115 (2013.01); C12N 2501/12 (2013.01); C12N 2501/15 (2013.01); C12N 2501/155 (2013.01); C12N 2501/16 (2013.01); C12N 2501/237 (2013.01); C12N 2501/415 (2013.01); C12N 2502/14 (2013.01); C12N 2506/02 (2013.01); C12N 2506/45 (2013.01);
Abstract

Provided is a selective method for inducing differentiation from pluripotent stem cells to enterocyte-like cells. Also provided is an excellent enterocyte-like cell expressing drug-metabolizing enzymes and drug transporters. More specifically, provided is an enterocyte-like cell having properties closer to those of primary enterocytes, which are difficult to acquire. The foregoing is achieved by adding an ALK5 inhibitor (SB431542), Wnt3a, and EGF to a culture system of definitive endoderm cells obtained by differentiation induction from pluripotent stem cells and extending a culture time. The foregoing is also achieved by introducing CDX2 gene and/or FOXA2 gene into the pluripotent stem cells or the definitive endoderm cells. The foregoing is also achieved by overlaying a basement membrane matrix on the enterocyte-like cells.


Find Patent Forward Citations

Loading…